Mechanistically, PA demonstrated the ability to cross the blood‐brain barrier and modulate brain pathology‐associated PA metabolism, thereby enhancing the cognitive function of AD mice by activating FFAR3, which regulated downstream signaling pathways, including JNK phosphorylation and BDNF expression. This evidence concerns the gene BDNF and Alzheimer disease.